Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO
|
7 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
BREAST CANCER, SUSCEPTIBILITY TO
|
24 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
8 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Li-Fraumeni Syndrome 2
|
11 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
PROSTATE CANCER, SUSCEPTIBILITY TO
|
6 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Neoplastic Syndromes, Hereditary
|
6387 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 1.000 | 32 | 2001 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.800 | 0.929 | 28 | 2001 | 2016 | |||||
Mantle cell lymphoma
|
19 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||
Breast Carcinoma
|
2793 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.900 | 0.895 | 19 | 2003 | 2017 | |||||
Hereditary pancreatitis
|
108 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2003 | 2003 | |||||
Malignant neoplasm of prostate
|
1082 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2004 | 2008 | |||||
Prostate carcinoma
|
1168 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2004 | 2008 | |||||
Malignant neoplasm of thyroid
|
103 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.020 | 1.000 | 2 | 2004 | 2015 | |||||
Neoplasms
|
1644 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.020 | 1.000 | 2 | 2004 | 2016 | |||||
Thyroid carcinoma
|
145 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.020 | 1.000 | 2 | 2004 | 2015 | |||||
Thyroid Neoplasm
|
135 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.020 | 1.000 | 2 | 2004 | 2015 | |||||
Colon Carcinoma
|
275 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Malignant neoplasm of kidney
|
22 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Malignant tumor of colon
|
688 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.710 | 1.000 | 1 | 2004 | 2004 | |||||
Prostate cancer, familial
|
25 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Renal carcinoma
|
21 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Carcinoma, Lobular
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1 | 2005 | 2005 | ||||||
Colorectal Carcinoma
|
1962 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.090 | 0.889 | 9 | 2006 | 2013 | |||||
Malignant Neoplasms
|
1641 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.090 | 1.000 | 9 | 2006 | 2013 |